Raymond James Financial’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-163,181
Closed -$785K 5305
2025
Q4
$785K Sell
163,181
-2,053
-1% -$9.93K ﹤0.01% 3946
2025
Q3
$836K Sell
165,234
-10,707
-6% -$47.3K ﹤0.01% 3794
2025
Q2
$709K Sell
175,941
-2,799
-2% -$9.11K ﹤0.01% 3789
2025
Q1
$488K Sell
178,740
-17,236
-9% -$61.8K ﹤0.01% 3952
2024
Q4
$833K Buy
+195,976
New +$746K ﹤0.01% 3573

Other funds holding SRTA

Raymond James Financial's SRTA Position: Q1 2026 in Review

Raymond James Financial sold out of Strata Critical Medical Inc (SRTA) in Q1 2026, closing a stake of 163,181 shares — an estimated $785K sold.

Raymond James Financial first reported a position in SRTA in Q4 2024 and held it in 5 quarters. The position peaked at $836K in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Raymond James Financial reported no remaining Strata Critical Medical Inc position as of Q1 2026 after selling out during the quarter.
  • Raymond James Financial sold 163,181 Strata Critical Medical Inc shares in Q1 2026, an estimated $785K.
  • Raymond James Financial first reported a position in Strata Critical Medical Inc in Q4 2024 and held it in 5 quarters.
  • Raymond James Financial's Strata Critical Medical Inc position peaked at $836K in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.